UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

COVID-19, coagulopathy and venous thromboembolism: more questions than answers

Internal and emergency medicine, 2020-11, Vol.15 (8), p.1375-1387

2020

Volltextzugriff (PDF)

Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol

Trials, 2020-06, Vol.21 (1), p.574-5, Article 574

2020

Volltextzugriff (PDF)

Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention

Cancers, 2024-05, Vol.16 (9), p.1769

2024

Volltextzugriff (PDF)

COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)

Blood transfusion = Trasfusione del sangue, 2020-05, Vol.18 (3), p.167-169

2020

Volltextzugriff (PDF)

Potential mechanisms of vaccine-induced thrombosis

European journal of internal medicine, 2022-11, Vol.105, p.1-7

2022

Volltextzugriff (PDF)

Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? No

Internal and emergency medicine, 2015-09, Vol.10 (6), p.647-650

Marietta, Marco

2015

Volltextzugriff (PDF)

Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines

Internal and emergency medicine, 2021-08, Vol.16 (5), p.1113-1119

2021

Volltextzugriff (PDF)

More on: ‘COVID‐19 coagulopathy in Caucasian patients’

British journal of haematology, 2020-06, Vol.189 (6), p.1059-1060

2020

Volltextzugriff (PDF)

Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial"

Blood transfusion = Trasfusione del sangue, 2020-05, Vol.18 (3), p.239-240

2020

Volltextzugriff (PDF)

Monkeypox outbreak: after COVID-19, another challenge for the hemostatic system?

Internal and emergency medicine, 2022-11, Vol.17 (8), p.2179-2183

2022

Volltextzugriff (PDF)

Non-replacement therapy for haemophilia treatment: fetching the east by the west

Blood transfusion = Trasfusione del sangue, 2018-09, Vol.16 (5), p.408-409

2018

Volltextzugriff (PDF)

Hemostasis in acute liver and kidney failure: nothing is as it seems

Kidney international, 2013-07, Vol.84 (1), p.22-24

2013

Volltextzugriff (PDF)

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

Gastroenterology (New York, N.Y. 1943), 2012-11, Vol.143 (5), p.1253-1260.e4

2012

Volltextzugriff (PDF)

Effects of Anti-vitamin k oral anticoagulants on bone and cardiovascular health

European journal of internal medicine, 2020-09, Vol.79, p.1-11

2020

Volltextzugriff (PDF)

Use of recombinant factor VIIa in a thrombocytopenic patient with spontaneous intracerebral haemorrhage

Thrombosis and haemostasis, 2005-02, Vol.93 (2), p.381

2005

Volltextzugriff (PDF)

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review

Advances in therapy, 2023-01, Vol.40 (1), p.41-66

2023

Volltextzugriff (PDF)

Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis

European journal of internal medicine, 2021-03, Vol.85, p.27-33

2021

Volltextzugriff (PDF)

Direct oral anticoagulants for atrial fibrillation in patients with congenital factor VII deficiency

European journal of haematology, 2019-07, Vol.103 (1), p.67-69

2019

Volltextzugriff (PDF)

Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review

Advances in therapy, 2020-05, Vol.37 (5), p.1910-1932

2020

Volltextzugriff (PDF)

Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)

Blood transfusion = Trasfusione del sangue, 2021-07, Vol.19 (4), p.281-283

2021

Volltextzugriff (PDF)

A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns

The European journal of contraception & reproductive health care, 2023-12, Vol.28 (6), p.308-312

2023

Volltextzugriff (PDF)

Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study)

Internal and emergency medicine, 2018-06, Vol.13 (4), p.527-534

2018

Volltextzugriff (PDF)

Is there a role for intervention radiology for the treatment of lower limb deep vein thrombosis in the era of direct oral anticoagulants? A comprehensive review

European journal of internal medicine, 2018-06, Vol.52, p.13-21

2018

Volltextzugriff (PDF)

Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality

European journal of internal medicine, 2019-01, Vol.59, p.27-33

2019

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

ThemaPeripheral Vascular Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

COVID-19, coagulopathy and venous thromboembolism: more questions than answers

Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol

Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention

Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial

COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)

Potential mechanisms of vaccine-induced thrombosis

Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? No

Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines

More on: ‘COVID‐19 coagulopathy in Caucasian patients’

Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial"

Monkeypox outbreak: after COVID-19, another challenge for the hemostatic system?

Non-replacement therapy for haemophilia treatment: fetching the east by the west

Hemostasis in acute liver and kidney failure: nothing is as it seems

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

Effects of Anti-vitamin k oral anticoagulants on bone and cardiovascular health

Use of recombinant factor VIIa in a thrombocytopenic patient with spontaneous intracerebral haemorrhage

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review

Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis

Direct oral anticoagulants for atrial fibrillation in patients with congenital factor VII deficiency

Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review

Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)

A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns

Is there a role for intervention radiology for the treatment of lower limb deep vein thrombosis in the era of direct oral anticoagulants? A comprehensive review

Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality

Aktive Filter

Suchergebnisse filtern